⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for borderline resectable pancreatic cancer

Every month we try and update this database with for borderline resectable pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot StudyNCT02148549
Patients With B...
FIRINOX
20 Years - 74 YearsWakayama Medical University
Divestment for Artery-involved Pancreatic CancerNCT03443921
Pancreatic Canc...
Locally Advance...
Neoadjuvant The...
Borderline Rese...
Artery Divestme...
Nab-paclitaxel
18 Years - 80 YearsThe First Affiliated Hospital with Nanjing Medical University
Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryNCT00833859
Pancreatic Neop...
GTX (gemcitabin...
stereotactic bo...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic CancerNCT02459652
Pancreatic Canc...
S-1
Radiation Thera...
20 Years - 75 YearsJapan Adjuvant Study Group of Pancreatic Cancer
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic CancerNCT04894643
Pancreatic Canc...
Proton Therapy
Proton Ions
Nab-PACLitaxel
Gemcitabine
Capecitabine
Surgical resect...
18 Years - EBG MedAustron GmbH
Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot StudyNCT02148549
Patients With B...
FIRINOX
20 Years - 74 YearsWakayama Medical University
A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in PatientsNCT01661088
Pancreatic Canc...
FOLFIRINOX
Intensity-modul...
Surgical Explor...
18 Years - University of Michigan Rogel Cancer Center
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPCNCT04855331
Borderline Rese...
Laparoscopic pa...
Open pancreatod...
18 Years - 80 YearsFudan University
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerNCT04698915
SBRT
Borderline Rese...
Unresectable Pa...
Drug GC4711
Placebo
18 Years - Galera Therapeutics, Inc.
Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic CancerNCT04894643
Pancreatic Canc...
Proton Therapy
Proton Ions
Nab-PACLitaxel
Gemcitabine
Capecitabine
Surgical resect...
18 Years - EBG MedAustron GmbH
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerNCT03850769
Borderline Rese...
nab-paclitaxel ...
18 Years - 70 YearsPeking Union Medical College Hospital
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerNCT02717091
Borderline Rese...
FOLFIRINOX
gemcitabine + n...
20 Years - 75 YearsNagoya University
Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)NCT06384560
Borderline Rese...
Pembrolizumab
18 Years - Amsterdam UMC, location VUmc
Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryNCT00833859
Pancreatic Neop...
GTX (gemcitabin...
stereotactic bo...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic AdenocarcinomaNCT05083247
Pancreatic Neop...
Pancreatic Aden...
Borderline Rese...
mFOLFIRINOX or ...
Isotoxic High-D...
Surgery
18 Years - Erasme University Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: